IL13-PE38: Clinical Trials

1 trial of IL13-PE38, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow IL13-PE38: new trials by email Literature Review of IL13-PE38 trials Research Report on IL13-PE38

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
IL13-PE38QQR, surgery and catheter placement (2 procedures), prolifespan 20 with carmustine implant (GLIADELĀ® Wafer) - Glioblastoma Multiforme
Phase 3CompletedINSYS Therapeutics Inc3002004-02-012011-06-06

Conditions studied

Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)

Sponsors

INSYS Therapeutics Inc (1)

Countries

Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)